🇳🇱 Netherlands Country × Condition
heart failure Clinical Trials in Netherlands
Active clinical trials for heart failure with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands
Active Trials in Netherlands (3)
NCT07547540 Phase 1
Recruiting
A Study of LY3971297 in Participants With Heart Failure
Enrollment
90 pts
Country
🇳🇱 Netherlands
Eli Lilly and Company
View Trial → NCT07539766
Recruiting
OBESE-HFpEF: Towards Preventing Obesity Related HFpEF
Enrollment
250 pts
Country
🇳🇱 Netherlands
Zuyderland Medisch Centrum
View Trial → NCT07304817 Phase 2
Recruiting
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
Enrollment
100 pts
Country
🇳🇱 Netherlands
University Medical Center Groningen
View Trial → Frequently Asked Questions
How many heart failure clinical trials are active in Netherlands?
There are currently 3 active clinical trials for heart failure with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a heart failure clinical trial in Netherlands?
To join a heart failure clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are heart failure trials in Netherlands?
Active heart failure trials in Netherlands span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology